Assembly Biosciences, Inc.ASMBNASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-6M

+84.8% YoY

Free Cash Flow

$-41M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	6	0	7	29↑298.2%	0
Gross Profit	6	-69↓1204.6%	-42↑39.6%	29↑168.3%	0
Operating Income	-133	-94↑29.1%	-65↑31.3%	-45↑29.7%	-12↑73.3%
Net Income	-130	-93↑28.3%	-61↑34.2%	-40↑34.4%	-6↑84.8%
EBITDA	-91	-93↓2.1%	-64↑30.6%	-45↑29.4%	-12↑73.2%
EPS Diluted	-36.00	-22.82↑36.6%	-13.38↑41.4%	-6.69↑50.0%	-0.55↑91.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	46	52↑14.9%	20↓62.1%	38↑93.3%	58↑52.4%
Total Current Assets	154	97↓37.1%	134↑38.0%	116↓13.7%	255↑120.4%
Total Assets	191	102↓46.7%	137↑34.4%	119↓12.9%	258↑116.2%
Total Current Liabilities	16	16↑1.4%	39↑140.7%	48↑21.9%	49↑2.0%
Total Liabilities	22	19↓13.6%	96↑400.4%	86↓10.4%	51↓40.8%
Total Equity	169	83↓51.1%	41↓50.3%	33↓18.8%	207↑519.8%
Total Debt	6	3↓46.5%	2↓32.4%	3↑31.9%	3↓14.9%
Net Debt	-39	-49↓25.0%	-17↑64.3%	-35↓101.5%	-56↓58.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-93	-84↑9.6%	23↑126.9%	-51↓324.8%	-41↑19.6%
Capital Expenditure	-3	-0↑96.7%	-0↓150.0%	-0↑89.0%	-0↓135.7%
Free Cash Flow	-96	-85↑12.4%	22↑126.6%	-51↓327.4%	-41↑19.5%
Stock-Based Comp	5	7↑25.9%	5↓22.4%	3↓39.1%	5↑49.9%
Net Change in Cash	-14	7↑149.1%	-33↓579.7%	19↑156.8%	20↑8.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance